Dr. Sham Mailankody, MD
Claim this profileMemorial Sloan Kettering Cancer Center
Studies Multiple Myeloma
Studies Plasma Cell Neoplasm
8 reported clinical trials
10 drugs studied
Affiliated Hospitals
Clinical Trials Sham Mailankody, MD is currently running
Talquetamab
for Multiple Myeloma
The researchers are doing this study to find out whether talquetamab is an effective treatment after BCMA CAR Tcell therapy for people with relapsed or refractory multiple myeloma. All participants in this study will have already received the BCMA CAR T-cell therapy ide-cel for their disease.
Recruiting1 award Phase 218 criteria
CB-011
for Multiple Myeloma
This is a Phase 1 study to evaluate the safety of CB-011 (the study treatment), an allogeneic chimeric antigen receptor (CAR-T) cell therapy that targets the B cell maturation antigen (BCMA), to determine the best dose of CB-011, and to assess the effectiveness of CB-011 in treating multiple myeloma that has come back (relapsed) or that is no longer responding to other treatment (refractory).
Recruiting1 award Phase 14 criteria
More about Sham Mailankody, MD
Clinical Trial Related8 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Sham Mailankody, MD has experience with
- MCARH109
- Lenalidomide
- Cyclophosphamide
- EGFRt/BCMA-41BBz CAR T Cell
- Talquetamab
- MCARH125
Breakdown of trials Sham Mailankody, MD has run
Multiple Myeloma
Plasma Cell Neoplasm
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sham Mailankody, MD specialize in?
Sham Mailankody, MD focuses on Multiple Myeloma and Plasma Cell Neoplasm. In particular, much of their work with Multiple Myeloma has involved treating patients, or patients who are undergoing treatment.
Is Sham Mailankody, MD currently recruiting for clinical trials?
Yes, Sham Mailankody, MD is currently recruiting for 2 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Sham Mailankody, MD has studied deeply?
Yes, Sham Mailankody, MD has studied treatments such as MCARH109, Lenalidomide, Cyclophosphamide.
What is the best way to schedule an appointment with Sham Mailankody, MD?
Apply for one of the trials that Sham Mailankody, MD is conducting.
What is the office address of Sham Mailankody, MD?
The office of Sham Mailankody, MD is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.